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Abstract
Background: It has been reported that some single nucleotide polymorphisms (SNPs) of the angiotensin converting 
enzyme (ACE) gene and the endothelial nitric oxide synthase (eNOS) gene are associated with the development of 
systemic lupus erythematosus (SLE) and the progression of nephropathy. The aim of this study was to evaluate the 
possible association between six SNPs (A-5466C, T-3892C, A-240T, C1237T, G2215A and A2350G) of the ACE gene and two 
SNPs (T-786C and G894T) of the eNOS gene with lupus nephropathy in a northern Chinese population.
Methods: In this study, 225 patients with lupus nephropathy were compared to 232 healthy controls, matched by 
gender, age and ethnicity. Following the extraction of genomic DNA from the leukocytes in the peripheral blood, the 
genotypes of the eight selected SNPs were determined by the method of PCR-RFLP; the haplotypes were inferred 
using PHASE 2.1. The associations between the SNPs and the risk of lupus nephropathy were analyzed using Chi-square 
test and Logistic regression with SPSS13.0 software.
Results: Statistically significant differences of the allele frequency distribution of three SNPs (A-5466C, A2350G and 
G894T) were observed between cases and controls (P < 0.05). Among the 53 haplotypes identified, the frequencies of 
five haplotypes (CTTCGA, ACTTAA, ACATGG, ACACGG and ATTCGA) were significantly different between cases and 
controls (P < 0.05).
Conclusions: Our study indicated an association between the risk of lupus nephropathy and the sequence variations 
of both the ACE gene and the eNOS gene, which may play an important role in the pathogenesis of lupus nephropathy 
in the northern Chinese population. Further studies are warranted to validate our findings.
Background
Systemic lupus erythematosus (SLE) is a complex autoim-
mune disease involving environmental, genetic and hor-
monal elements [1-3]; also it is a multisystem disease with
a variable course and a wide range of clinical manifesta-
tions[4], such as lupus nephropathy. Renal injury in SLE
is one of the most serious complications and its patho-
genesis has not yet been completely clarified [1].
It has been extensively documented that genetic factors
play an important role in the development and progres-
sion of both SLE and lupus nephropathy [5-7]. Many
studies have showed the critical role of the SNPs of the
ACE gene and the eNOS gene in the process of the occur-
rence and progression of SLE [8-10].
As is widely known that the reninangiotensin system
(RAS) is usually involved in the progression of renal dis-
eases [11]. ACE affects various clinical manifestations
through the reninangiotensin system by promoting the
formation of angiotensin II and inactivating bradykinin
[2]. In human, the ACE gene is located on chromosome
17q22-q24 [12] and is expressed in a wide range of tis-
sues, such as lung, vascular endothelium, kidney, heart
and testes [9]. Many studies, including one study in a Chi-
nese population [13], have suggested that a 250 bp inser-
tion/deletion (I/D) polymorphism of the ACE gene was
associated with SLE and renal injury [1,13]. Recent stud-
ies have reported that several SNPs (A-5466C, T-3892C,
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A-240T, CJ237T, G2215A and A2350G) of the ACE gene
may affect the risk of certain autoimmune diseases such
as essential hypertension, left ventricular hypertrophy,
IgA nephropathy, diabetic nephropathy and so on [14-
16]. Therefore, we presume that these SNPs of the ACE
gene may also play an important role in the molecular
mechanisms of lupus nephropathy.
Nitric oxide (NO) plays an important role in the patho-
genesis of SLE, with an elevated level of expression in SLE
patients than in healthy controls [17]. NO synthesis is
tightly regulated by nitric oxide synthases (NOS), the lat-
ter has three isoforms: neuronal (nNOS), inducible
(iNOS) and endothelial (eNOS) [18]. The eNOS gene is
located on chromosome 7q35-q36 [19], which is an
important factor in the process of immunity reaction and
the production of NO. It has been reported that two SNPs
(T-786C and G894T) of the eNOS gene were associated
with the susceptibility of vascular, infectious and autoim-
mune diseases, such as resistant hypertension, ischemic
stroke, essential hypertension, and lacunar infarction [20-
22]. These SNPs may alter the level of the eNOS gene
expression or change the protein product of the gene, and
is relevant either to the pathogenesis of SLE or the pro-
gression of specific manifestations of diseases such as
atherosclerosis and renal complications [23,24]. There-
fore, the eNOS gene is a candidate gene for the analysis of
SLE susceptibility [8,25].
However, the associations between the above men-
tioned SNPs and the risk of lupus nephropathy have not
been evaluated in the Chinese population. The aim of the
present study is to investigate the association of these
SNPs with lupus nephropathy in a northern Chinese pop-
ulation.
Methods
Subjects
Totally 225 lupus nephropathy patients were recruited
from the department of rheumatology, the Second Affili-
ated Hospital of Harbin Medical University, located in
northern China. All patients were classified as lupus
nephropathy according to the American College of Rheu-
matology (ACR) renal criteria [26,27] or the evidence of
the renal biopsy for lupus nephropathy. The methods
used for the determination of urinalysis and blood pres-
sure, as well as the diagnostic criteria for serum creati-
nine and proteinuria were following the World Health
Organization (WHO) criteria[28].
The control subjects were enrolled from the individuals
who underwent a health examination in the Second Affil-
iated Hospital of Harbin Medical University. They had no
history of rheumatism and immunology diseases, nor any
abnormal clinical examination results. Both cases and
controls were matched by gender, age and ethnicity. All
study participants provided informed consent and
donated peripheral blood. This study was approved by
the appropriate local authority. The major characteristics
of the study subjects were listed in Table 1.
Using the standard method of phenol-chloroform
extraction, the DNA samples were prepared from periph-
eral blood samples anti-coagulated with ACD.
Genotyping of the SNPs of the ACE gene and the eNOS gene
The information of the six SNPs of the ACE gene and two
SNPs of the eNOS gene were shown in Table 2, as well as
the details of the primers, restriction enzymes and the
l e n gt h  o f  d i g e s t ed  fr a gm e n ts.  T h e  PCR  r e a c t i o n s  w e r e
performed in a final volume of 25 μl, containing approxi-
mately 50 ng genomic DNA, 0.5 μM each primer, 0.2 mM
dNTP, 2.0 mM MgCl2, 50 mM KCl, 10 mM Tris HCl (pH
8.4) and 0.2 U Taq DNA Polymerase (TaKaRa). All reac-
tions were performed using a Perkin Elmer 9700. The
PCR products were digested and then separated by 2-3%
agarose gel electrophoresis.
Statistical analysis
After the genotypes of each individual were determined,
genotype and allele frequencies were calculated by direct
counting. Deviations from Hardy-Weinberg equilibrium
(HWE) were tested for all SNPs in control subjects. As
these loci of the ACE gene were tightly linked in a LD
block, we conducted a haplotype analysis using PHASE
2.1 software. The associations between the allele frequen-
cies and genotype frequencies and lupus nephropathy
were analyzed by the Chi-square test and Logistic regres-
sion using SPSS13.0 software for Windows. The relative
Table 1: Clinical and laboratory characteristics of healthy controls and lupus nephropathy
Characteristics Control Lupus nephropathy
n 232 225
Mean age (years) mean ± SD 34.9 ± 9.8 35.2 ± 10.1
Sex ratio (Female: Male) 85/147 81/144
24-hour proteinuria (mg) - > 500
persistent hematuria - yes
s-Cr(mg/dL) - > 1.3Li et al. BMC Medical Genetics 2010, 11:94
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Table 2: The information of the primers and restriction enzymes
SNP Location Primer sequence Enzyme Amplification 
length
The length of 
digested fragments
F-gccatgtcacatgtattatagga EcoRV 133 bp 24 bp + 109 bp
ACE A-5466C 5'UTR
R-cgtctttggaaacttgtctgc
F-atagtgtatatagggcttggtac PstI 114 bp 90 bp + 24 bp
ACE T-3892C 5'UTR
R-agaagatatttgcaaagtatgtactg
F-tgtcactccggaggcgggaggct XbaI 168 bp 145 bp + 23 bp
ACE A-240T 5'UTR
R-gagaaagggcctcctctctct
F-agtgcacacgggtcacgatg BsmBI 287 bp 95 bp +192 bp
ACE C1237T exon8
R-caccaagtagccaaagggcag
F-cacaccctgaagtacggcac HaeII 131 bp 109 bp + 22 bp
ACE G2215A exon14
R-tcctccagctcctgggcag
F-ctgacgaatgtgatggccgc BstUI 122 bp 103 bp + 19 bp
ACE A2350G exon16
R-ttgatgagttccacgtatttcg
F-tggagatgatggtgtacccca MspI 180 bp 94 bp +46 bp +42 bp
eNOS T-786C 5'UTR
R-gcctccacccccaccctgtc
F-aaggcaggagacagtggatgga Ban II 248 bp 163 bp + 85 bp
eNOS G894T Exon7
R- cccagtcaatccctttggtgctca
risk of minor alleles compared with major alleles was esti-
mated using odds ratio (OR) and 95% confidence interval
(CI), P-values less than 0.05 were considered statistically
significant.
Results
Genotype distribution of the ACE gene between patients 
with lupus nephropathy and controls
All loci were in Hardy-Weinberg equilibrium in controls
(p  > 0.05). The allele frequencies of the six SNPs (A-
5466C, T-3892C, A-240T, C1237T, G2215A and A2350G)
of the ACE  gene were 0.318 (-5466C), 0.411 (-3892T),
0.402 (-240T), 0.298 (1237C), 0.387 (2215A) and 0.158
(2350G) in cases, and 0.429 (-5466C), 0.457 (-3892T),
0.379 (-240T), 0.295 (1237C), 0.358 (2215A) and 0.244
(2350G) in controls (Table 3).
There was a significant difference in the frequency of
the -5466C allele between cases and controls (P = 0.001;
OR = 1.612, 95%CI = 1.230-2.113). Similarly, the associa-
tion between the 2350G allele and the risk of lupus neph-
ropathy was significant (P = 0.001; OR = 1.719, 95%CI =
1.235-2.391). However, there was no significant associa-
tion between the other four SNPs (T-3892C, A-240T,
C1237T  and  G2215A) and lupus nephropathy in this
sample (P > 0.05; Table 3).
As shown in Table 3, significant associations was
observed between the frequencies of the genotypes of -
5466AA/-5466AC+-5466CC and the risk of lupus neph-
ropathy (P = 0.002; OR = 0.559, 95%CI = 0.384-0.816).
Such association were also seen between the genotypes of
2350AA/2350AG+2350GG and lupus nephropathy (P =
0.003; OR = 0.558, 95%CI = 0.377-0.827).
Fifty-three haplotypes were identified in these samples
and the frequencies of twenty-four haplotypes among
them were listed in Table 4. The most common haplotype
in lupus nephropathy patients was ACATGA, followed by
ACATAA, CCATAA, and CCATGA and so on. Among
them, the frequency of the CTTCGA haplotype in lupus
nephropathy patients (2.89%) was higher than in healthy
controls (0.22%, P  = 0.001). The associations betweenLi et al. BMC Medical Genetics 2010, 11:94
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other four haplotypes (ACTTAA, ACATGG, ACACGG
and ATTCGA) and lupus nephropathy were also signifi-
cant (P  < 0.05). However, there were no association
between the other haplotypes and lupus nephropathy (P
> 0.05).
Genotype distribution of the eNOS gene between patients 
with lupus nephropathy and controls
All loci were in Hardy-Weinberg equilibrium in controls
(P > 0.05). The allele frequencies were 0.176 (-786C) and
0.073 (894T) in cases, and 0.166 (-786C) and 0.129 (894T)
in controls (Table 3). There was a significant difference in
the allelic frequency of the 894T allele between cases and
controls (P = 0.005; OR = 1.877, 95%CI = 1.201-2.932),
while the association was not significant between the
genotype frequency of the -786C and lupus nephropathy
(P = 0.700; OR = 0.934, 95%CI = 0.662-1.319). As shown
in Table 3, the association between the 894GG/
894GT+894TT  genotypes and lupus nephropathy was
statistically significant (P = 0.008; OR = 0.520, 95%CI =
0.318-0.850).
Since both the ACE gene and the eNOS gene were asso-
ciated with the risk of lupus nephropathy, we evaluated
the interaction of the two genes, using SNPs that were
significantly associated with the disease. Neither the
interaction of ACE A-5466C and eNOS G-894T nor the
interaction of ACE A-2350G and eNOS G-894T were sig-
nificant, P values were 0.093 and 0.950, respectively.
Discussion
Lupus nephropathy happens at a high frequency in
patients with SLE, and it has been suggested to be related
to abnormal regulation of the complex system consisting
of the RAS and the NO system, both regulating vascular
tone and inflammation. These two systems may have a
profound effect in the pathogenesis and progression of
SLE and the development of lupus nephropathy. Multiple
genetic and environmental factors may be implicated in
the evolution of lupus nephropathy. Different genetic
variants contribute to the SLE phenotype from popula-
tions of different genetic backgrounds are becoming
increasingly apparent [29]. I n  r e c e n t  y e a r s ,  c o m p l e t e
genome scans have tried to search for SLE susceptibility
loci [30], two candidate genes identified are the ACE gene
and the eNOS  gene [31], which are inter-related [32].
ACE is a key component of RAS and it converts angio-
tensin I to II [33]. It inhibits the progression pace of the
majority of chronic nephropathies [34]. eNOS is an
important isoform of NOS, which plays an important role
in autoimmune diseases [23,35]. Polymorphisms of the
eNOS gene are relevant to the pathogenesis of certain dis-
eases correlate with SLE [36]. As a family-based associa-
tion analysis has already shown an association between
ACE G-261T and SLE in a Chinese population [37], we
did not test this locus in our study. Six SNPs (A-5466C, T-
3892C,  A-240T, C1237T,  G2215A and A2350G) of the
ACE  gene and two SNPs (T-786C  and  G894T) of the
eNOS gene have been selected since they may affect the
susceptibility to some autoimmune diseases [36].
In this study, significant differences in genotype distri-
bution of two SNPs (A-5466C and A2350G) of the ACE
gene were observed between cases and controls. The dif-
ferences are similar to previous reports [38,39], and are
strong predictors of plasma ACE levels [40,41]. No asso-
ciation was observed between the allelic frequency distri-
bution of other SNPs and lupus nephropathy, although
they have been studied extensively in high prevalence of
renal disorders among hypertensive [42,43]. Our results
suggested that ACE -5466C and ACE 2350G allele play a
significant protect role in the pathology of renal disease,
and  ACE -5466A allele in homozygote individuals and
ACE 2350A allele in dominant genetic model were risk
allele for lupus nephropathy.
The association between some of the haplotypes and
lupus nephropathy were shown to be significant. Among
them, the haplotypes ACTTAA, ACACGG and
ACATGG play protective role in the renal injury in SLE,
while haplotypes ATTCGA and CTTCGA were risk fac-
tors. To the best of our knowledge, this is the first study
focusing on the SNPs of ACE gene and eNOS gene in Chi-
nese population.
NO is an important biological molecule, which has a
critical role in many biological systems. It has been iden-
tified as a potent mediator of immune and inflammatory
response. Studies have shown that the levels of NO are
significantly elevated in SLE patients in comparison with
controls. A correlation has been found between serum
NO and SLE disease activity[17]. For example, the T-
786C and its interaction with G894T have impact on the
basal nitric oxide activity of renal circulation, essential
hypertension and diabetic nephropathy in multi-ethnical
population [44,45]. In this study, the association between
the variations of the eNOS gene (G894T) and the pres-
ence of nephropathy in SLE was significant, with the
eNOS 894T allele play a significant protect role in the
pathology of renal injury in SLE, and eNOS 894G allele in
dominant genetic model were susceptibility gene for
lupus nephropathy. However, no such association was
found with the eNOS T-786C.
The above inconsistency could be due in part to the
heterogeneity of the ACE gene and the eNOS gene among
different ethnic groups [21,46], since it is often the case
that the same SNP has different roles in different popula-
tions. Another reason may be the unclear stratification of
the patients with the lupus nephropathy, such as first
attack or recurrence and the age of onset and so on. Fur-
thermore, environmental factors for cases and controls
were not available in this study, which limited the analysisLi et al. BMC Medical Genetics 2010, 11:94
http://www.biomedcentral.com/1471-2350/11/94
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Table 3: Allele frequencies and genotype frequencies of the SNPs of the ACE gene and the eNOS gene in cases and controls
SNP Genotype Control N = 232 (%) Lupus nephropathy 
N = 225 (%)
p OR (95%CI)
AA 79(34.05) 108(48.44) 0.002* 0.559(0.384-0.816)
AC 107(46.12) 91(40.44) 0.221 1.260(0.870-1.826)
ACEA-5466C CC 46(19.83) 26(11.56) 0.015* 1.893(1.124-3.186)
A allele 265(57.11%) 307(68.22%) 0.001* 0.620(0.473-0.813)
C allele 199(42.89%) 143(31.78%) 0.001* 1.612(1.230-2.113)
TT 50(21.55) 43(19.11) 0.517 1.163(0.737-1.835)
TC 112(48.28) 99(44.00) 0.359 1.188(0.822-1.717)
ACE T-3892C CC 70(30.17) 83(36.89) 0.128 0.739(0.501-1.092)
T allele 212(45.69%) 185(41.11%) 0.163 1.205(0.927-1.566)
C allele 252(54.31%) 265(58.89%) 0.163 0.830(0.639-1.078)
AA 93(40.09) 79(35.11) 0.272 1.236(0.846-1.807)
AT 102(43.97) 111(47.84) 0.250 0.806(0.558-1.164)
ACEA-240T TT 37(15.95) 35(15.56) 0.908 1.030(0.623-1.704)
A allele 273 (62.07%) 269(59.78%) 0.772 0.962(0.739-1.252)
T allele 191(37.93%) 181(40.22%) 0.772 1.040(0.799-1.354)
ACE C1237T CC 24(10.34) 19(8.44) 0.487 1.251(0.665-2.353)
CT 89(38.36) 96(42.67) 0.349 0.836(0.575-1.216)
TT 119(51.29) 110(48.89) 0.607 1.101(0.763-1.589)
C allele 137(29.53%) 134(29.78%) 0.934 0.988(0.744-1.312)
T allele 327(70.47%) 316(70.22%) 0.934 1.012(0.762-1.344)
GG 98(42.24) 87(38.67) 0.436 1.160(0.798-1.686)
AG 102(43.97) 102(45.33) 0.769 0.946(0.654-1.368)
ACEG2215A AA 32(13.79) 36(16.00) 0.507 0.840(0.501-1.407)
G allele 298(64.22%) 276(61.33%) 0.366 1.132(0.865-1.480)
A allele 166(35.78%) 174(38.67%) 0.366 0.884(0.676-1.156)
AA 138(59.48) 163(72.44) 0.003* 0.558(0.377-0.827)
AG 75(32.33) 53(23.56) 0.037* 1.550(1.026-2.343)
ACEA2350G GG 19 (8.19) 9(4.00) 0.062 2.141(0.947-4.838)
A allele 351(75.65%) 379(84.22%) 0.001* 0.582(0.418-0.810)
G allele 113(24.35%) 71(15.78%) 0.001* 1.719(1.235-2.391)
CC 9(3.88) 11(4.89) 0.598 0.785(0.319-1.933)
TC 59(25.43) 57(25.33) 0.981 1.005(0.660-1.532)
eNOS T-786C TT 164(70.69) 157(69.78) 0.831 1.045(0.699-1.560)
T allele 387(83.41%) 371(82.44%) 0.700 1.070(0.758-1.511)
C allele 77(16.59%) 79(17.56%) 0.700 0.934(0.662-1.319)
eNOS G894T GG 179(77.16) 195(86.67) 0.008* 0.520(0.318-0.850)
GT 46(19.83) 27(12.00) 0.022* 1.814(1.083-3.037)
TT 7(3.02) 3(1.33) 0.215 2.312(0.593-9.019)
G allele 404(87.07%) 417(92.67%) 0.005* 0.533(0.341-0.833)
T allele 60(12.93%) 33(7.33%) 0.005* 1.877(1.201-2.932)
* p < 0.05Li et al. BMC Medical Genetics 2010, 11:94
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of the interaction between genetic factors and environ-
mental factors, and further the estimation of adjusted
ORs. Finally, the sample size for this study was relatively
small due to the limited time of the collection of cases,
the result of this study need validation.
Although some limitations do exist in this study, ours is
an innovative study with some promising findings that
contribute to the evaluation of genetic risk factors for
lupus nephropathy. The clues provided in this study call
for further research, other association studies, as well as
functional studies are warranted to prove the association
from multiple aspects. For the analysis of the association
between these SNPs and the progression of this disease.
Further studies, with larger sample sizes, are necessary to
determine the contribution of these alleles to lupus neph-
ropathy progression.
Conclusions
Our study shows that two SNPs (-5466C and 2350G) of
the ACE gene and the one SNP (G894T) of the eNOS gene
were associated with the susceptibility of lupus nephrop-
athy. Five haplotypes (CTTCGA, ACTTAA, ACATGG,
ACACGG and ATTCGA) were found to contribute to the
risk of lupus nephropathy, suggesting an important role
they played in the pathology of lupus nephropathy.
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Table 4: Haplotype frequencies of the ACE gene in cases and controls
Haplotype Control 2N = 464 (%) Lupus nephropathy 
2N = 450 (%)
p OR (95%CI)
ACATGA 52(11.21) 49(10.89) 0.878 1.033(0.683-1.562)
CCATAA 23(4.96) 30(6.67) 0.269 0.730(0.417-1.277)
ACATAA 21(4.53) 31(6.89) 0.123 0.641(0.362-1.133)
CCATGA 22(4.74) 25(5.56) 0.577 0.846(0.470-1.524)
ATTCGA 12(2.59) 23(5.11) 0.047* 0.493(0.242-1.003)
ACTTGA 22(4.74) 20(4.44) 0.830 1.070(0.576-1.989)
ATATGA 25(5.39) 13(2.89) 0.058 1.914(0.967-3.791)
CCTTAA 32(6.90) 23(5.11) 0.256 1.375(0.792-2.389)
ATTTAA 13(2.80) 21(4.67) 0.136 0.589(0.291-1.191)
ACACGA 13(2.80) 17(3.78) 0.408 0.734(0.352-1.530)
ATATAA 6(1.29) 14(3.11) 0.060 0.408(0.155-1.071)
CCATGG 16(3.45) 11(2.44) 0.370 1.425(0.654-3.106)
ATACGA 11(2.37) 16(3.56) 0.290 0.659(0.302-1.435)
ACTTAA 20(4.31) 6(1.33) 0.007* 3.333(1.326-8.379)
ATTTGA 16(3.45) 10(2.22) 0.265 1.571(0.705-3.501)
CCTTAG 6(1.29) 14(3.11) 0.060 0.408(0.155-1.071)
CTTCGA 1(0.22) 13(2.89) 0.001* 0.073(0.009-0.557)
ACACGG 11(2.37) 3(0.67) 0.036* 3.618(1.003-13.056)
ACTCGA 5(1.08) 9(2.00) 0.256 0.534(0.177-1.605)
ACATGG 11(2.37) 3(0.67) 0.036* 3.618(1.003-13.056)
CCACGA 10(2.16) 4(0.89) 0.119 2.456(0.765-7.888)
CCATAG 6(1.29) 6(1.33) 0.957 0.969(0.310-3.028)
ACACAA 3(0.65) 9(2.00) 0.072 0.319(0.086-1.186)
ACTCAA 7(1.51) 10(2.22) 0.425 0.674(0.254-1.786)
* p < 0.05Li et al. BMC Medical Genetics 2010, 11:94
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